These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12113061)

  • 41. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
    Sturlan S; Beinhauer BG; Oberhuber G; Huang L; Aasen AO; Rogy MA
    Anticancer Res; 2002; 22(5):2547-54. PubMed ID: 12529962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cancer cachexia and targeting chronic inflammation: a unified approach to cancer treatment and palliative/supportive care.
    MacDonald N
    J Support Oncol; 2007 Apr; 5(4):157-62; discussion 164-6, 183. PubMed ID: 17500503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Editorial update on emerging drugs for cancer cachexia.
    Murphy KT; Lynch GS
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):5-9. PubMed ID: 22229463
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 'cancer cachectic factor'.
    Tisdale MJ
    Support Care Cancer; 2003 Feb; 11(2):73-8. PubMed ID: 12560934
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin.
    Diament MJ; Peluffo GD; Stillitani I; Cerchietti LC; Navigante A; Ranuncolo SM; Klein SM
    Cancer Invest; 2006 Mar; 24(2):126-31. PubMed ID: 16537180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Medroxyprogesterone acetate in the management of cancer cachexia.
    Madeddu C; Macciò A; Panzone F; Tanca FM; Mantovani G
    Expert Opin Pharmacother; 2009 Jun; 10(8):1359-66. PubMed ID: 19445562
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antimyopathic effects of carnitine and nicotine.
    Laviano A; Meguid MM; Guijarro A; Muscaritoli M; Cascino A; Preziosa I; Molfino A; Rossi Fanelli F
    Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):442-8. PubMed ID: 16778574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cancer cachexia: it's time for more clinical trials.
    Bossola M; Pacelli F; Tortorelli A; Doglietto GB
    Ann Surg Oncol; 2007 Feb; 14(2):276-85. PubMed ID: 17094025
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pernicious cachexia: a different view of cancer.
    Zajicek G
    Anticancer Res; 1999; 19(6A):4907-12. PubMed ID: 10697603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of animal models for head and neck cancer cachexia.
    Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
    Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer cachexia syndrome in head and neck cancer patients: Part II. Pathophysiology.
    George J; Cannon T; Lai V; Richey L; Zanation A; Hayes DN; Shores C; Guttridge D; Couch M
    Head Neck; 2007 May; 29(5):497-507. PubMed ID: 17390378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
    Shirasaka T; Taguchi T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
    Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
    Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
    Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
    Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
    Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
    Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
    Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer cachexia syndrome in head and neck cancer patients: part I. Diagnosis, impact on quality of life and survival, and treatment.
    Couch M; Lai V; Cannon T; Guttridge D; Zanation A; George J; Hayes DN; Zeisel S; Shores C
    Head Neck; 2007 Apr; 29(4):401-11. PubMed ID: 17285641
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The pivotal role of cytokines in muscle wasting during cancer.
    Argilés JM; Busquets S; López-Soriano FJ
    Int J Biochem Cell Biol; 2005 Aug; 37(8):1609-19. PubMed ID: 15878837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The role of proteasome in pathophysiology of cancer cachexia].
    Wcisło G; Korniluk J; Wojtuń S
    Pol Merkur Lekarski; 2004; 17 Suppl 1():47-9. PubMed ID: 15603347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of recombinant human growth hormone in HIV-associated wasting and cachexia: pathophysiology and rationale for treatment.
    Gelato M; McNurlan M; Freedland E
    Clin Ther; 2007 Nov; 29(11):2269-88. PubMed ID: 18158071
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.